Divalproex Sodium
Overview
Divalproex Sodium is a medication primarily used to treat seizure disorders, bipolar disorder, and to prevent migraine headaches. It is a stable co-ordination compound comprised of sodium valproate and valproic acid in a 1:1 molar relationship.
API suppliers (12)
Suppliers of Divalproex Sodium evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 11 of 12 suppliers.
6 of 12 hold a GMP certificate on record in the EU or UK registers
- Hetero Drugs LimitedIndia1 active DMF GMP on record
- SCI PHARMTECH INCTaiwan1 active DMF
- PCASFrance1 active DMF GMP on record
- Suven Life Sciences LimitedIndia1 active DMF
- KATWIJK CHEMIE BVNetherlands1 active DMF GMP on record
- ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF GMP on record
- Wockhardt UsaUnited Kingdom1 active DMF
- Genesen Labs LtdIndia
- CHENG FONG CHEMICAL CO LTDTaiwan
- PROCOS SPAItaly GMP on record
- SELOC FRNCE
- CILAG AGSwitzerland GMP on record
Therapeutic areas
Do you supply Divalproex Sodium? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.